Détail de l'auteur
Auteur Kathryn-L TERRY |
Documents disponibles écrits par cet auteur (3)

![]()
Article
Shruthi MAHALINGAIAH ; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School (Boston MA, Etats-Unis) ; Jaime-E HART ; Lauren-A WISE ; Kathryn-L TERRY ; Renée BOYNTON-JARRETT ; Stacey-A MISSMER ; Pierre BUEKENS, éd. |[BDSP. Notice produite par INIST-CNRS IR0xq8JC. Diffusion soumise à autorisation]. Previous studies evaluating the association of prenatal exposure to diethylstilbestrol (DES), a potent endocrine disruptor, with incidence of uterine leiomyomata [...]![]()
Article
Weiva SIEH ; Elisa-V BANDERA ; Andrew BERCHUCK ; Jenny CHANG-CLAUDE ; Daniel-W CRAMER ; Jennifer-A DOHERTY ; Anna FELBERG ; Marc-T GOODMAN ; Estrid HOGDALL ; Allan JENSEN ; Susan-J JORDAN ; Lambertus-A KIEMENEY ; Melony-G KING ; Susanne-Kruger KJAER ; Galina LURIE ; Tamara MAREES ; Leon-F MASSUGER ; Valerie MCGUIRE ; Dianne MILLER ; Kirsten MOYSICH ; Roberta-B NESS ; Sara-H OLSON ; Rachel PALMIERI WEBER ; Celeste-Leigh PEARCE ; Malcolm-C PIKE ; Harvey RISCH ; Lorna RODRIGUEZ-RODRIGUEZ ; Mary-Anne ROSSING ; Anja RUDOLPH ; Shannon SALVADOR ; Joellen-M SCHILDKRAUT ; Kathryn-L TERRY ; Anne-M VAN ALTENA ; Penelope-M WEBB ; Alice-S WHITTEMORE ; Anna-H. Wu ; Cancer Institute of New Jersey. Umdnj-Robert Wood Johnson Medical School. New Brunswick. NJ. USA ; Department of Epidemiology. Biostatistics and Health Technology Assessment. Radboud University Nijmegen Medical Centre. Nijmegen. NLD ; Department of Gynecology. Radboud University Nijmegen Medical Centre. Nijmegen. NLD ; Department of Obstetrics and Gynecology. University of British Columbia. Vancouver. BC. CAN ; Department of Obstetrics. Gynecology and Reproductive Biology. Harvard Medical School. And Obstetrics and Gynecology Epidemiology Center. Brigham and Women's Hospital. Boston. MA. USA ; Ovarian Cancer Association Consortium. INC ; Population Health Department. Queensland Institute of Medical Research. Brisbane Queensland. AUS |[BDSP. Notice produite par INIST-CNRS m9p8R0x7. Diffusion soumise à autorisation]. Background Tubal ligation is a protective factor for ovarian cancer, but it is unknown whether this protection extends to all invasive histological subtypes or bo[...]![]()
Article
Kathryn-L TERRY ; Daniel-W CRAMER ; DE VIVO (Immaculata) : USA. Channing Laboratory. Department of Medicine. Brigham and Women's Hospital and Harvard Medical School. Boston. MA. ; SLUSS (Patrick-M) : USA. Reproductive Endocrine Unit. Department of Medicine. Massachusetts General Hospital. Boston. MA. ; TITUS-ERNSTOFF (Linda) : USA. Norris Cotton Cancer Center and the Departments of Community and Family Medicine and of Medicine. Dartmouth Medical School. Lebanon. NH. ; Harvard Medical School. Brigham and Women's Hospital. Obstetrics and Gynecology Epidemiology Center. Boston. MA. USA |[BDSP. Notice produite par INIST-CNRS Dqa2R0x8. Diffusion soumise à autorisation]. Evidence suggests a role for progesterone in ovarian cancer development. Progesterone exerts its effect on target cells by interacting with its receptor. Thus, ge[...]